Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MRTX | ACLX | RNA | ||
| Company | Mirati Therapeutics | Arcellx Inc | Avidity Biosciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 58.86 | 78.95 | 42.24 | ||
| High | 58.99 | 82.97 | 45.25 | ||
| Low | 58.54 | 78.03 | 42.19 | ||
| Last | 58.70 | 80.55 | 44.63 | ||
| Change | -0.10 | +2.56 | +2.44 | ||
| % Change | -0.17% | +3.28% | +5.78% | ||
| Volume | 20,994,400 | 689,200 | 4,715,500 | ||
| 20-Day Average Volume | 2,385,220 | 411,330 | 1,351,160 | ||
| Previous Close | 58.80 | 77.99 | 42.19 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 58.94 | 71.73 | 42.36 | ||
| 20-Day Raw Stochastic | 17.39% | 87.18% | 79.40% | ||
| 20-Day Relative Strength | 61.06% | 71.88% | 56.18% | ||
| Weighted Alpha | -3.70 | +104.07 | +306.29 | ||
| Today's Opinion | 88% Buy | 88% Buy | 80% Buy | ||
| Previous Opinion | 88% Buy | 88% Buy | 40% Buy | ||
| Last Month's Opinion | 100% Buy | 72% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.98% since 01/12/24 | +8.27% since 09/11/24 | +10.09% since 09/11/24 | ||
| Low | 58.54 on 01/22/24 | 72.35 on 09/12/24 | 40.13 on 09/12/24 | ||
| High | 59.27 on 01/16/24 | 82.97 on 09/18/24 | 45.25 on 09/18/24 | ||
| 1-Month | |||||
| %Chg | -0.41% since 12/22/23 | +23.39% since 08/16/24 | -0.78% since 08/16/24 | ||
| Low | 58.54 on 01/22/24 | 64.10 on 09/04/24 | 39.35 on 09/06/24 | ||
| High | 59.46 on 01/12/24 | 82.97 on 09/18/24 | 46.00 on 08/21/24 | ||
| 3-Month | |||||
| %Chg | +5.42% since 10/20/23 | +49.69% since 06/18/24 | +16.44% since 06/18/24 | ||
| Low | 55.14 on 10/27/23 | 49.00 on 08/05/24 | 36.63 on 07/05/24 | ||
| High | 59.46 on 01/12/24 | 82.97 on 09/18/24 | 48.80 on 07/29/24 | ||
| 6-Month | |||||
| %Chg | +87.48% since 07/21/23 | +16.55% since 03/18/24 | +86.50% since 03/18/24 | ||
| Low | 27.30 on 08/08/23 | 47.88 on 05/10/24 | 21.56 on 04/04/24 | ||
| High | 64.41 on 10/06/23 | 82.97 on 09/18/24 | 48.80 on 07/29/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,117,688 | 4,172,698 | 4,034,925 | ||
| Shares Outstanding, K | 70,148 | 53,503 | 95,637 | ||
| Annual Sales | 12,440,000 | 110,320,000 | 9,560,000 | ||
| Annual Net Income | -740,870,000 | -70,690,000 | -212,220,000 | ||
| Last Quarter Sales | 16,400,000 | 27,380,000 | 2,050,000 | ||
| Last Quarter Net Income | -161,900,000 | -27,200,000 | -70,790,000 | ||
| 60-Month Beta | 0.77 | 0.23 | 0.89 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.49 on 11/06/23 | -0.51 on 08/08/24 | -0.65 on 08/09/24 | ||
| Latest Earnings Date | 02/27/24 | 11/11/24 | 08/13/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||